These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

555 related articles for article (PubMed ID: 33436624)

  • 41. Remdesivir Strongly Binds to Both RNA-Dependent RNA Polymerase and Main Protease of SARS-CoV-2: Evidence from Molecular Simulations.
    Nguyen HL; Thai NQ; Truong DT; Li MS
    J Phys Chem B; 2020 Dec; 124(50):11337-11348. PubMed ID: 33264025
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease.
    Agostini ML; Andres EL; Sims AC; Graham RL; Sheahan TP; Lu X; Smith EC; Case JB; Feng JY; Jordan R; Ray AS; Cihlar T; Siegel D; Mackman RL; Clarke MO; Baric RS; Denison MR
    mBio; 2018 Mar; 9(2):. PubMed ID: 29511076
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mutations in the SARS-CoV-2 RNA-dependent RNA polymerase confer resistance to remdesivir by distinct mechanisms.
    Stevens LJ; Pruijssers AJ; Lee HW; Gordon CJ; Tchesnokov EP; Gribble J; George AS; Hughes TM; Lu X; Li J; Perry JK; Porter DP; Cihlar T; Sheahan TP; Baric RS; Götte M; Denison MR
    Sci Transl Med; 2022 Aug; 14(656):eabo0718. PubMed ID: 35482820
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative assessment of favipiravir and remdesivir against human coronavirus NL63 in molecular docking and cell culture models.
    Wang Y; Li P; Rajpoot S; Saqib U; Yu P; Li Y; Li Y; Ma Z; Baig MS; Pan Q
    Sci Rep; 2021 Dec; 11(1):23465. PubMed ID: 34873274
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A Systematic Study on the Optimal Nucleotide Analogue Concentration and Rate Limiting Nucleotide of the SARS-CoV-2 RNA-Dependent RNA Polymerase.
    Vatandaslar H
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955442
    [TBL] [Abstract][Full Text] [Related]  

  • 46. SARS-CoV-2 RNA-dependent RNA polymerase as a therapeutic target for COVID-19.
    Vicenti I; Zazzi M; Saladini F
    Expert Opin Ther Pat; 2021 Apr; 31(4):325-337. PubMed ID: 33475441
    [No Abstract]   [Full Text] [Related]  

  • 47. Virtual Screening and Quantum Chemistry Analysis for SARS-CoV-2 RNA-Dependent RNA Polymerase Using the ChEMBL Database: Reproduction of the Remdesivir-RTP and Favipiravir-RTP Binding Modes Obtained from Cryo-EM Experiments with High Binding Affinity.
    Tsuji M
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232311
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Binding of Remdesivir to SARS-CoV-2 RNA-Dependent RNA Polymerase May Pave The Way Towards the Design of Potential Drugs for COVID-19 Treatment.
    Agoni C; Soliman MES
    Curr Pharm Biotechnol; 2021; 22(11):1520-1537. PubMed ID: 33109039
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Beneficial effect of combinational methylprednisolone and remdesivir in hamster model of SARS-CoV-2 infection.
    Ye ZW; Yuan S; Chan JF; Zhang AJ; Yu CY; Ong CP; Yang D; Chan CC; Tang K; Cao J; Poon VK; Chan CC; Cai JP; Chu H; Yuen KY; Jin DY
    Emerg Microbes Infect; 2021 Dec; 10(1):291-304. PubMed ID: 33538646
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Plant-Derived Natural Non-Nucleoside Analog Inhibitors (NNAIs) against
    Naidu SAG; Mustafa G; Clemens RA; Naidu AS
    J Diet Suppl; 2023; 20(2):254-283. PubMed ID: 34850656
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Allosteric Activation of SARS-CoV-2 RNA-Dependent RNA Polymerase by Remdesivir Triphosphate and Other Phosphorylated Nucleotides.
    Wang B; Svetlov V; Wolf YI; Koonin EV; Nudler E; Artsimovitch I
    mBio; 2021 Jun; 12(3):e0142321. PubMed ID: 34154407
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phylogenetic Analysis and Structural Perspectives of RNA-Dependent RNA-Polymerase Inhibition from SARs-CoV-2 with Natural Products.
    Khan A; Khan M; Saleem S; Babar Z; Ali A; Khan AA; Sardar Z; Hamayun F; Ali SS; Wei DQ
    Interdiscip Sci; 2020 Sep; 12(3):335-348. PubMed ID: 32617855
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Remdesivir and Ledipasvir among the FDA-Approved Antiviral Drugs Have Potential to Inhibit SARS-CoV-2 Replication.
    Pirzada RH; Haseeb M; Batool M; Kim M; Choi S
    Cells; 2021 Apr; 10(5):. PubMed ID: 33946869
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Discovery and optimization of 2-((1H-indol-3-yl)thio)-N-benzyl-acetamides as novel SARS-CoV-2 RdRp inhibitors.
    Zhang GN; Zhao J; Li Q; Wang M; Zhu M; Wang J; Cen S; Wang Y
    Eur J Med Chem; 2021 Nov; 223():113622. PubMed ID: 34147744
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lycorine, a non-nucleoside RNA dependent RNA polymerase inhibitor, as potential treatment for emerging coronavirus infections.
    Jin YH; Min JS; Jeon S; Lee J; Kim S; Park T; Park D; Jang MS; Park CM; Song JH; Kim HR; Kwon S
    Phytomedicine; 2021 Jun; 86():153440. PubMed ID: 33376043
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 2-((1H-indol-3-yl)thio)-N-phenyl-acetamides: SARS-CoV-2 RNA-dependent RNA polymerase inhibitors.
    Zhao J; Zhang G; Zhang Y; Yi D; Li Q; Ma L; Guo S; Li X; Guo F; Lin R; Luu G; Liu Z; Wang Y; Cen S
    Antiviral Res; 2021 Dec; 196():105209. PubMed ID: 34801588
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The NSP14/NSP10 RNA repair complex as a Pan-coronavirus therapeutic target.
    Rona G; Zeke A; Miwatani-Minter B; de Vries M; Kaur R; Schinlever A; Garcia SF; Goldberg HV; Wang H; Hinds TR; Bailly F; Zheng N; Cotelle P; Desmaële D; Landau NR; Dittmann M; Pagano M
    Cell Death Differ; 2022 Feb; 29(2):285-292. PubMed ID: 34862481
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Structural basis for backtracking by the SARS-CoV-2 replication-transcription complex.
    Malone B; Chen J; Wang Q; Llewellyn E; Choi YJ; Olinares PDB; Cao X; Hernandez C; Eng ET; Chait BT; Shaw DE; Landick R; Darst SA; Campbell EA
    Proc Natl Acad Sci U S A; 2021 May; 118(19):. PubMed ID: 33883267
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Halting coronavirus polymerase.
    Kirchdoerfer RN
    J Biol Chem; 2020 Apr; 295(15):4780-4781. PubMed ID: 32277065
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hepatitis C virus drugs that inhibit SARS-CoV-2 papain-like protease synergize with remdesivir to suppress viral replication in cell culture.
    Bafna K; White K; Harish B; Rosales R; Ramelot TA; Acton TB; Moreno E; Kehrer T; Miorin L; Royer CA; García-Sastre A; Krug RM; Montelione GT
    Cell Rep; 2021 May; 35(7):109133. PubMed ID: 33984267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.